Karani Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$947K Sell
1,030
-104
-9% -$105K 0.78% 29
2025
Q4
$1.22M Sell
1,134
-22
-2% -$21K 1% 21
2025
Q3
$882K Sell
1,156
-169
-13% -$126K 0.7% 25
2025
Q2
$1.03M Buy
1,325
+600
+83% +$466K 1% 23
2025
Q1
$599K Buy
+725
New +$603K 0.63% 31

Other funds holding LLY

Karani Asset Management's LLY Position: Q1 2026 in Review

Karani Asset Management reduced its Eli Lilly (LLY) stake by 9.2% in Q1 2026, selling an estimated $105K and leaving 1,030 shares worth $947K. The position accounts for 0.78% of the portfolio, ranked #29.

Karani Asset Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.22M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Karani Asset Management held 1,030 shares of Eli Lilly worth $947K as of Q1 2026.
  • Karani Asset Management sold 104 Eli Lilly shares in Q1 2026, an estimated $105K.
  • Eli Lilly made up 0.78% of Karani Asset Management's portfolio in Q1 2026, its #29 holding.
  • Karani Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Karani Asset Management's Eli Lilly position peaked at $1.22M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Karani Asset Management's 13F filing for Q1 2026, filed 15 May 2026.